Ultrasound Imaging for Vascular Access (CANSCAN Trial)

N/A

Recruiting

Research Sponsored by Vexev Pty Ltd

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

1. Referred to a study site for chronic renal replacement therapy OR referred to a study site for management of CKD.

3. Greater than or equal to 21 years of age at the time of written informed consent.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from enrollment to the end of viable assessment window at 90 days.

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if dialysis clinic staff can use a specific ultrasound system to perform scans on patients' upper limbs."

Who is the study for?

This trial is for adults over 21 who need chronic renal replacement therapy or have chronic kidney disease (CKD) management. Participants must understand the study and consent to it.

What is being tested?

The study tests if dialysis clinic staff can use the Vexev Ultrasound Imaging System to map out blood vessels in the arm for patients with vascular access issues.

What are the potential side effects?

Since this trial involves non-invasive ultrasound imaging, side effects are minimal but may include discomfort during scanning or minor skin irritation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am referred for treatment of chronic kidney disease or for dialysis.

Select...

I am 21 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from enrollment to the end of viable assessment window at 90 days.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from enrollment to the end of viable assessment window at 90 days.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to the end of viable assessment window at 90 days. for reporting.